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Introduction: Poor reporting of adverse drug reactions (ADRs) by doctors is a major hindrance 
to successful pharmacovigilance. The present study was designed to assess first-year residents’ 
knowledge of ADR reporting.
Methods: First-year postgraduate doctors at a private medical college completed a structured 
questionnaire. The responses were analyzed by nonparametric methods.
Results: All doctors were aware of the term “adverse drug reactions.” Fifty percent of the 
doctors reported being taught about ADR reporting during their undergraduate teaching, and 
50% had witnessed ADRs in their internship training. Ten percent of patients suffering an ADR 
observed and reported by doctors required prolonged hospitalization for treatment as a result. 
Only 40% of interns reported the ADRs that they observed, while 60% did not report them. 
Twenty-eight percent reported ADRs to the head of the department, 8% to an ADR monitoring 
committee, and 4% to the pharmacovigilance center. Eighty-six percent of the doctors surveyed 
felt that a good knowledge of undergraduate clinical pharmacology therapeutics would have 
improved the level of ADR reporting.
Conclusion: The knowledge of first-year doctors regarding ADR reporting is quite poor. There 
is a dire need to incorporate ADR reporting into undergraduate teaching, and to reinforce this 
during internships and periodically thereafter.
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Introduction
An adverse drug reaction (ADR) is defined as an unintended and noxious response to 
a drug that occurs at doses normally used for the prophylaxis, diagnosis, or therapy of 
diseases, or for the modification of physiological function.1 ADRs have medical as well 
as economic consequences, leading to increased patient morbidity and mortality.2 This 
has given rise to “pharmacovigilance”, which is defined as the science and activities 
relating to the detection, assessment, understanding, and prevention of adverse effects 
of drugs, or any other drug-related problems.3
Spontaneous monitoring is the foundation of successful pharmacovigilance. In 
developed countries, the contribution of residents and doctors is significant and has 
contributed to signal detection of ADRs that were previously undetected.4 However, 
in India, spontaneous monitoring has resulted in lower rates of reporting, and so the 
Indian contribution to the World Health Organization (WHO) Uppsala Monitoring 
Centre database is meager.5
One reason for this is lack of awareness about the detection, communication, and 
reporting of ADRs, and there is no intensive teaching about ADR reporting in the 
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undergraduate curriculum and no periodic   reinforcement 
of ADR monitoring in internship and postgraduate   studies.6 
As well as this, doctors may underreport ADRs due to 
financial incentives, fear of litigation, and ambition to 
publish. Some doctors have inadequate ADR-related 
knowledge and may believe that all serious ADRs will 
have been documented before a drug is marketed, that an 
ADR should be reported only when there is no doubt about 
its cause, that an ADR must be serious to be reported, and 
there may be an attitude of indifference or ignorance to 
the ADR. Sometimes, doctors who are asked why ADRs 
were not reported give excuses like lethargy, disinterest 
in reporting, or a lack of time to find and complete the 
ADR form.7,8
Rates of reporting can be improved by promoting 
awareness of the importance of ADR reporting and the 
procedures for doing so, and this is best done during under-
graduate teaching. Traditional forms of   pharmacology 
teaching take place through didactic lectures and are 
more teacher-  centered, with the main emphasis on learn-
ing facts about drugs.9 The Medical Council of India has 
recommended teaching undergraduate students about ADR 
monitoring.
In order to improve ADR monitoring, it is imperative to 
assess the current knowledge, attitude, and practices of doctors. 
The current study was performed to assess these factors in a 
group of first year doctors in a private medical college. It was 
hoped that the results would help in the designing of an under-
graduate curriculum to encourage spontaneous ADR reporting 
among doctors.
Methods
This was a cross-sectional questionnaire-based study 
performed in a private teaching and tertiary care hospital 
in Rajasthan, the Mahatma Gandhi Medical College and 
Hospital (MGMC), Jaipur, India. Approval was given by 
the institutional ethics committee.
The study group were first-year postgraduate doctors, 
who were pursuing their studies in the medical, surgical, 
paraclinical, and preclinical branches of medical science. 
A structured questionnaire was based on the work of 
Oshikoya et al and Tobaiqy et al.10,11 The questionnaire sought 
information regarding participants’ demographics, awareness 
about the term ADR, knowledge of ADR reporting, and 
ADR management in their internship positions. Also, the 
questionnaire sought feedback regarding ways to improve 
students’ knowledge of ADR reporting during undergraduate 
training in clinical pharmacology and therapeutics. Most of 
the questions in the questionnaire were objective and mostly 
required a “yes” or “no” response (Appendix I).
The questionnaire was presented to 50 first-year post-
graduate doctors who indicated that they were willing to 
participate in the study after the purpose of the study was 
explained to them. They were asked to complete the ques-
tionnaire and return it immediately; those who were too 
busy to complete the questionnaire were asked to return it 
the next day, or as soon as possible. Results were analyzed 
by nonparametric statistical tests.
Results
Forty-four percent of study participants were aged between 
21 and 25 years, 34% were aged between 26 and 30 years, 
18% were aged between 31 and 35 years, and 4% were aged 
over 35 years. Fifty-eight percent of participants were male, 
and 42% were female (Table 1).
All participants had studied ADRs in undergraduate 
teaching and were conversant with it. Fifty percent of 
participants said that they had been taught about ADR 
reporting in their undergraduate teaching, while the 
remaining 50% said that they had not. Fifty-four percent of 
participants said that they had not discussed ADR report-
ing during their internship, while 46% said that they had 
discussed this.
Fifty percent of participants had witnessed ADRs dur-
ing their internship training, and of these, 20% reported 
that the likely cause of ADRs were drug–drug interac-
tions, 18% reported medication errors, and 36% reported 
idiosyncratic reactions. Of the ADRs witnessed, 22% 
of cases did not require any hospitalization, while 34% 
required short hospitalization, and 10% required prolonged 
hospitalization. Some 84% doctors reported that they 
thought that ADRs are avoidable, while 14% thought that 
they are unavoidable. Some 74% thought that ADRs are 
predictable.
Eighty-six percent of doctors reported that a good knowl-
edge of undergraduate Curriculum Practical Training (CPT) 
teaching would have improved the ADR reporting (Table 2). 
Only 40% of doctors reported the ADRs they observed, with 
28% reporting these to their head of the department, 8% to the 
Table 1 Demographic profile of the study population
Age (years) Male:Female ratio
21–25 44% 58:42
26–30 34%
31–35 18%
.35 4%
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ADR monitoring committee, and 4% to the pharmacovigilance 
center (Table 3).
Discussion
The current study suggests that the rate of ADR reporting 
is poor among first-year postgraduate doctors. Only 40% 
reported the ADRs they witnessed, with most reporting these 
to the head of the department, some to the ADR monitoring 
committee, and a smaller number to the pharmacovigilance 
center. These results are quite similar to the findings of 
Li et al.12 Another study from a large tertiary care hospital 
in north India showed that most ADR reporting is by post-
graduate doctors.
Self-reporting through questionnaires, as was done in the 
current study, has a number of weaknesses: the most impor-
tant of these are underreporting and biased reporting.13
It is imperative for doctors to know how to report an 
ADR, and who to report to. If doctors do not know these 
two things this will affect spontaneous reporting, so it is 
important for awareness programs to be in place to educate 
first-year postgraduate doctors. Poor spontaneous reporting 
is an indicator of poor management and dissemination of 
ADR monitoring.
ADR reporting should be intensively taught during 
undergraduate study, and this should be reinforced at the start 
of internships as well as periodically thereafter through con-
tinuous education programs.14 The doctors who participated 
in this study also suggested organizing training programs, 
introducing a quick and easy method of ADR reporting, and 
providing small gestures such as an appreciation note to keep 
up the motivation for pharmacovigilance activities.
It has been demonstrated that an educational intervention 
can increase a physician’s awareness of ADRs, and enable 
them to incorporate the knowledge into clinical practice.15 
Another study on simplifying ADR reporting has indicated 
that the use of quick and easy methods of ADR reporting, 
such as introducing a drop box with ADR forms and alert 
cards, helps to promote reporting.16 Other suggestions include 
compulsory teaching and lectures on pharmacovigilance 
and ADR reporting for undergraduates, and it has been sug-
gested that students should be required to report at least three 
ADRs during their pharmacology training, and that interns 
be taught about ADR reporting during internship orienta-
tion programs. There should also be a strong collaboration 
between a hospital’s department of pharmacology and other 
clinical departments to help ensure proper and efficient ADR 
reporting, and also to provide pharmacovigilance awareness 
programs.
It is interesting to note that 60% of the interns who par-
ticipated in this study did not report ADRs they witnessed, 
which suggests that the practice of reporting the ADRs is poor 
among doctors. A recent study assessed doctors’ knowledge, 
attitude, and practices associated with ADR reporting and 
found that these were inadequate,17 while another study found 
that while prescribers were aware of ADRs, underreporting 
and a lack of knowledge of the reporting system were clearly 
evident.18 The findings of these studies suggests that doctors 
and the medical fraternity in general need to incorporate more 
study of ADRs and ADR reporting into the undergraduate 
curriculum.
In India, a nationwide pharmacovigilance program has 
been put in place to protect the health of patients by assuring 
drug safety, monitoring ADRs, and creating awareness of the 
importance of ADR reporting among health professionals. 
This program aims to make every medical college, private 
hospital, and autonomous institute an ADR monitoring cen-
ter, and will collaborate with the WHO Uppsala Monitoring 
Centre in Sweden.19 In India, ADR reporting by clinicians 
relies on spontaneous monitoring, and this has been the basis 
of the early warning system for regulatory action relating to 
drugs. All health care professionals including doctors, nurses, 
and pharmacists can report an ADR by completing an ADR 
form from the Central Drugs Standard Control Organization 
Table 2 Undergraduate teaching of ADRs and ADR reporting
Questions Responses (%)
Knew the term ADR before 100
Taught about ADR reporting in UG teaching 50
not discussed ADR reporting in internship 54
not seen any ADR 46
ADRs are avoidable 84
ADRs are predictable 74
Good knowledge in UG teaching could have 
improved ADR reporting
86
Abbreviations: ADR, adverse drug reaction; UG, undergraduate.
Table 3 Reporting of ADRs by first-year postgraduate doctors
How many reported the ADRs How many did not report
40% 60%
28% to head of department 8% to ADR monitoring committee 4% to pharmacovigilance center
Abbreviation: ADRs, adverse drug reactions.
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and submitting this to the pharmacology department. The 
pharmacology department then analyses the cause of the 
ADR and submits data to the WHO center.
Conclusion
The current study indicates that there is an urgent need to 
create awareness about ADR reporting in undergraduate 
teaching, with this being reinforced during internships. This 
would lay a solid foundation for doctors to ensure pharma-
covigilance in their future practice. A close relationship also 
needs to be created between doctors and pharmacovigilance 
centers, and the attitudes of residents and doctors to ADR 
monitoring must change so that they perceive this as an 
integral part of their clinical activities.
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Appendix I
Demographics
  1.  How old are you?
(a) #20 years  (b) 21–25 years   
(c) 26–30 years   (d) 31–35 years   
(e) $35 years
  2.  What is your sex?
(a) Male  (b) Female
  3.  Where did you do your undergraduate medical training?
(a) Mahatma Gandhi Medical College, Jaipur  (b) Other
  4.  If other, please name the institution? ……………………………..
Knowledge of adverse drug reactions (ADRs) and ADR reporting
  5.  Did you know the term ADRs before?
(a) Yes  (b) No
  6.  Have you witnessed any ADRs?
(a) Yes  (b) No
  7.  The likely cause of the ADRs was:
(a) drug–drug interaction (b) medication error (c) idiosyncratic reaction (d) others (please specify) …………………… 
  ………………….......................................................................................
  8.  If the above is yes, which of the following did it result in?
(a) No hospitalization     (b) Short hospitalization 
(c) Prolonged hospitalization   (d) Morbidity 
(e) Death
  9.  Do you consider the ADRs avoidable?
(a) Yes  (b) No
10.  Do you consider the ADRs predictable?
(a) Yes  (b) No
11.  Did you report the ADRs?
(a) Yes  (b) No
12.  If the above is yes, whom did you report to?
(a)   ADRs monitoring committee of the hospital   (b) National Pharmacovigilance Centre 
(c) Head of department   (d) Other (please specify) ………………………….................................
13.  Were you taught how to report ADR in your undergraduate CPT teaching?
(a) Yes  (b) No
14.  Do you think a good knowledge of undergraduate CPT teaching would have improved the ADR reporting?
(a) Yes  (b) No
15.  Has anybody ever discussed about ADR reporting with you in internship training?
(a) Yes  (b) No
16.  Do you know about the Pharmacovigilance programme of India?
(a) Yes  (b) No
17.   Any suggestions on improving ADR reporting knowledge by undergraduate training in clinical pharmacology and 
therapeutics?
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